AptarGroup (ATR) to Release Quarterly Earnings on Thursday

AptarGroup (NYSE:ATR) is scheduled to issue its quarterly earnings data after the market closes on Thursday, April 25th. Analysts expect the company to announce earnings of $1.12 per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link.

AptarGroup (NYSE:ATR) last released its quarterly earnings results on Friday, February 9th. The industrial products company reported $1.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.12 by $0.09. AptarGroup had a return on equity of 14.46% and a net margin of 8.16%. The business had revenue of $838.48 million during the quarter, compared to the consensus estimate of $842.50 million. During the same quarter in the previous year, the company posted $0.92 EPS. The business’s revenue was up 5.3% on a year-over-year basis. On average, analysts expect AptarGroup to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.

AptarGroup Stock Up 0.7 %

Shares of NYSE ATR opened at $140.38 on Tuesday. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.24 and a quick ratio of 0.83. The firm’s 50-day moving average is $140.61 and its two-hundred day moving average is $131.77. AptarGroup has a 12-month low of $111.63 and a 12-month high of $145.35. The company has a market capitalization of $9.29 billion, a PE ratio of 33.03, a price-to-earnings-growth ratio of 3.82 and a beta of 0.59.

AptarGroup Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 16th. Investors of record on Thursday, April 25th will be given a dividend of $0.41 per share. The ex-dividend date of this dividend is Wednesday, April 24th. This represents a $1.64 dividend on an annualized basis and a yield of 1.17%. AptarGroup’s dividend payout ratio (DPR) is currently 38.59%.

Insider Transactions at AptarGroup

In related news, CEO Stephan B. Tanda sold 32,000 shares of the firm’s stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $141.67, for a total transaction of $4,533,440.00. Following the completion of the sale, the chief executive officer now directly owns 159,024 shares in the company, valued at $22,528,930.08. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, CEO Stephan B. Tanda sold 32,000 shares of the business’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $141.67, for a total transaction of $4,533,440.00. Following the transaction, the chief executive officer now directly owns 159,024 shares in the company, valued at $22,528,930.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Monnas Giovanna Kampouri sold 2,000 shares of the stock in a transaction on Tuesday, March 12th. The stock was sold at an average price of $142.45, for a total value of $284,900.00. Following the transaction, the director now owns 9,648 shares of the company’s stock, valued at $1,374,357.60. The disclosure for this sale can be found here. Insiders sold a total of 37,500 shares of company stock valued at $5,318,280 in the last three months. 1.00% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the company. Wells Fargo & Company upped their price target on AptarGroup from $157.00 to $160.00 and gave the stock an “overweight” rating in a research note on Thursday, March 7th. Robert W. Baird raised shares of AptarGroup from a “neutral” rating to an “outperform” rating and upped their price target for the stock from $125.00 to $150.00 in a research report on Wednesday, January 3rd.

AptarGroup Company Profile

AptarGroup, Inc designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments.